These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22310817)

  • 1. Optimizing adherence to antiretroviral therapy.
    Sahay S; Reddy KS; Dhayarkar S
    Indian J Med Res; 2011 Dec; 134(6):835-49. PubMed ID: 22310817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering comprehensive home-based care programmes for HIV: a review of lessons learned and challenges ahead in the era of antiretroviral therapy.
    Wringe A; Cataldo F; Stevenson N; Fakoya A
    Health Policy Plan; 2010 Sep; 25(5):352-62. PubMed ID: 20144935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics, financing and implementation of HIV treatment as prevention: what will it take to get there?
    Wilson D; Taaffe J; Fraser-Hurt N; Gorgens M
    Afr J AIDS Res; 2014; 13(2):109-19. PubMed ID: 25174628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do the implementation outcome variables tell us about the scaling-up of the antiretroviral treatment adherence clubs in South Africa? A document review.
    Mukumbang FC; Orth Z; van Wyk B
    Health Res Policy Syst; 2019 Mar; 17(1):28. PubMed ID: 30871565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unearthing how, why, for whom and under what health system conditions the antiretroviral treatment adherence club intervention in South Africa works: A realist theory refining approach.
    Mukumbang FC; Marchal B; Van Belle S; van Wyk B
    BMC Health Serv Res; 2018 May; 18(1):343. PubMed ID: 29743067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.
    Haberer JE; Sabin L; Amico KR; Orrell C; Galárraga O; Tsai AC; Vreeman RC; Wilson I; Sam-Agudu NA; Blaschke TF; Vrijens B; Mellins CA; Remien RH; Weiser SD; Lowenthal E; Stirratt MJ; Sow PS; Thomas B; Ford N; Mills E; Lester R; Nachega JB; Bwana BM; Ssewamala F; Mbuagbaw L; Munderi P; Geng E; Bangsberg DR
    J Int AIDS Soc; 2017; 20(1):21371. PubMed ID: 28630651
    [No Abstract]   [Full Text] [Related]  

  • 7. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
    Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
    PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
    Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
    AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women.
    Hodgson I; Plummer ML; Konopka SN; Colvin CJ; Jonas E; Albertini J; Amzel A; Fogg KP
    PLoS One; 2014; 9(11):e111421. PubMed ID: 25372479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A realist approach to eliciting the initial programme theory of the antiretroviral treatment adherence club intervention in the Western Cape Province, South Africa.
    Mukumbang FC; Marchal B; Van Belle S; van Wyk B
    BMC Med Res Methodol; 2018 May; 18(1):47. PubMed ID: 29801467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.
    Krummenacher I; Spencer B; Du Pasquier S; Bugnon O; Cavassini M; Schneider MP
    Int J Clin Pharm; 2014 Aug; 36(4):716-24. PubMed ID: 24913358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence.
    Horberg MA; Hurley LB; Towner WJ; Allerton MW; Tang BT; Catz SL; Silverberg MJ; Quesenberry CP
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):183-90. PubMed ID: 22293551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploration of group-based HIV/AIDS treatment and care models in Sub-Saharan Africa using a realist evaluation (Intervention-Context-Actor-Mechanism-Outcome) heuristic tool: a systematic review.
    Mukumbang FC; Van Belle S; Marchal B; van Wyk B
    Implement Sci; 2017 Aug; 12(1):107. PubMed ID: 28841894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting.
    Jones L; Akugizibwe P; Clayton M; Amon JJ; Sabin ML; Bennett R; Stegling C; Baggaley R; Kahn JG; Holmes CB; Garg N; Obermeyer CM; Mack CD; Williams P; Smyth C; Vitoria M; Crowley S; Williams B; McClure C; Granich R; Hirnschall G
    Curr HIV Res; 2011 Sep; 9(6):416-28. PubMed ID: 21999777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.
    Grimwood A; Fatti G; Mothibi E; Malahlela M; Shea J; Eley B
    J Int AIDS Soc; 2012 May; 15(2):17381. PubMed ID: 22713255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review.
    Wouters E; Van Damme W; van Rensburg D; Masquillier C; Meulemans H
    BMC Health Serv Res; 2012 Jul; 12():194. PubMed ID: 22776682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.